BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29562274)

  • 1. MicroRNA-143 Targets ATG2B to Inhibit Autophagy and Increase Inflammatory Responses in Crohn's Disease.
    Lin XT; Zheng XB; Fan DJ; Yao QQ; Hu JC; Lian L; Wu XJ; Lan P; He XS
    Inflamm Bowel Dis; 2018 Mar; 24(4):781-791. PubMed ID: 29562274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-375 exacerbates knee osteoarthritis through repressing chondrocyte autophagy by targeting ATG2B.
    Li H; Li Z; Pi Y; Chen Y; Mei L; Luo Y; Xie J; Mao X
    Aging (Albany NY); 2020 Apr; 12(8):7248-7261. PubMed ID: 32335541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-143-3p targets ATG2B to inhibit autophagy and promote endothelial progenitor cells tube formation in deep vein thrombosis.
    Zhang W; Chen P; Zong H; Ding Y; Yan R
    Tissue Cell; 2020 Dec; 67():101453. PubMed ID: 33130456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-130a inhibits proliferation of vascular smooth muscle cells by suppressing autophagy via ATG2B.
    Zheng L; Wang Z; Li Z; Wang M; Wang W; Chang G
    J Cell Mol Med; 2021 Apr; 25(8):3829-3839. PubMed ID: 33611856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells.
    Gao S; Wang K; Wang X
    Neoplasma; 2020 Jul; 67(4):724-734. PubMed ID: 32726125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells.
    Wei J; Ma Z; Li Y; Zhao B; Wang D; Jin Y; Jin Y
    Mol Med Rep; 2015 Jan; 11(1):571-6. PubMed ID: 25322940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1303 Regulates Mycobacteria Induced Autophagy by Targeting Atg2B.
    Au KY; Pong JC; Ling WL; Li JC
    PLoS One; 2016; 11(1):e0146770. PubMed ID: 26771516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crocin exerts anti-proliferative and apoptotic effects on cutaneous squamous cell carcinoma via miR-320a/ATG2B.
    Bi X; Jiang Z; Luan Z; Qiu D
    Bioengineered; 2021 Dec; 12(1):4569-4580. PubMed ID: 34320900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy.
    Lu C; Chen J; Xu HG; Zhou X; He Q; Li YL; Jiang G; Shan Y; Xue B; Zhao RX; Wang Y; Werle KD; Cui R; Liang J; Xu ZX
    Gastroenterology; 2014 Jan; 146(1):188-99. PubMed ID: 24036151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway.
    Zhang J; Chen K; Tang Y; Luan X; Zheng X; Lu X; Mao J; Hu L; Zhang S; Zhang X; Chen W
    Cell Death Dis; 2021 Apr; 12(4):367. PubMed ID: 33824300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑143‑3p inhibits endometriotic stromal cell proliferation and invasion by inactivating autophagy in endometriosis.
    Yang H; Hu T; Hu P; Qi C; Qian L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.
    Zhao Y; Ma T; Chen W; Chen Y; Li M; Ren L; Chen J; Cao R; Feng Y; Zhang H; Shi R
    J Crohns Colitis; 2016 Jun; 10(6):703-12. PubMed ID: 26802080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-143 sensitizes acute myeloid leukemia cells to cytarabine via targeting ATG7- and ATG2B-dependent autophagy.
    Zhang H; Kang J; Liu L; Chen L; Ren S; Tao Y
    Aging (Albany NY); 2020 Oct; 12(20):20111-20126. PubMed ID: 33077697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease.
    Pierdomenico M; Cesi V; Cucchiara S; Vitali R; Prete E; Costanzo M; Aloi M; Oliva S; Stronati L
    Inflamm Bowel Dis; 2016 Feb; 22(2):315-26. PubMed ID: 26752466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.
    Szűcs D; Béres NJ; Rokonay R; Boros K; Borka K; Kiss Z; Arató A; Szabó AJ; Vannay Á; Sziksz E; Bereczki C; Veres G
    World J Gastroenterol; 2016 Jul; 22(26):6027-35. PubMed ID: 27468194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy inhibits cancer stemness in triple-negative breast cancer via miR-181a-mediated regulation of ATG5 and/or ATG2B.
    Park JW; Kim Y; Lee SB; Oh CW; Lee EJ; Ko JY; Park JH
    Mol Oncol; 2022 May; 16(9):1857-1875. PubMed ID: 35029026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease.
    Cheng X; Zhang X; Su J; Zhang Y; Zhou W; Zhou J; Wang C; Liang H; Chen X; Shi R; Zen K; Zhang CY; Zhang H
    Sci Rep; 2015 May; 5():10397. PubMed ID: 25997679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p/ATG2B/PTEN-AKT axis to mediate autophagy and pyroptosis.
    Chen X; Xue W; Zhang J; Peng J; Huang W
    Lipids Health Dis; 2023 Feb; 22(1):22. PubMed ID: 36759837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.